Study programmes
Pharmacology and Toxicology
Study program:
Pharmacology and Toxicology
SP code:
P0916D080025
Study form:
combined
Study type:
doctoral
Standard duration of study in years:
4
Language of instruction:
Czech
Title:
Ph.D.
Title:
No
More details
SP name in English:
Pharmacology and Toxicology
SP name in Latin:
Pharmacologia et toxicologia
SP profile:
academically oriented
SP characteristics
The Doctoral Program of Pharmacology and Toxicology is focused on the study of drug interactions with the organism in terms of pharmacokinetics, pharmacodynamics and drug toxicity. Students of this program extend the basic theoretical knowledge of pharmacology and toxicology and gain expertise in experimental work with state-of-the-art methodologies of molecular and cellular pharmacology and genetics - in vitro, in situ, ex vivo and in vivo. Depending on the specialization of the study, graduates are experts in various aspects of pharmacology, including mechanisms of drug effects, drug interactions, metabolism and excretion. The Study Program of Pharmacology and Toxicology is suitable not only for those interested in experimental research but also for those who wish to continue in clinical practice. The standard length of study is four years.
More details
Graduate profile for the public:
Graduate of the Doctoral Study Program of Pharmacology and Toxicology is a specialist in the field of theoretical, experimental and applied pharmacology and toxicology and shows the ability of independent creative work and thinking in the given field. Tutoring, as defined by an individual study plan, enables study from areas of molecular and cellular level, through the level of effects of substances on isolated organs or the whole organism. Areas of veterinary pharmacology and radiopharmaceuticals are also covered. It is obvious that the final expertise and experience vary among graduates depending on the individual study plan and their specialization during doctoral studies.
The graduate has acquired new knowledge and methodological approaches in relation to the scientific principles of drug development, assessing the properties and use of drugs in accordance with the principles of rational and individual therapy and evidence-based medicine. He/she is able to critically evaluate the latest knowledge in the biomedical field and respond to new technologies and trends. He/she is able to independently present the results of scientific work at international conferences and professional journals. He/she is able to communicate with biomedical specialists.
Graduates can find work in the laboratories of the pharmaceutical industry (e.g. preclinical/clinical research and development), hospitals (e.g. laboratories of molecular genetics), veterinary and nuclear medicine, academia/universities and research institutes.
By defending the dissertation thesis, the graduate demonstrates that he/she is capable of independent scientific work. Graduates will receive Ph.D. and meet the prerequisites for further career growth in the fields dealing with drugs and their therapeutic and toxic effects.
The graduate has acquired new knowledge and methodological approaches in relation to the scientific principles of drug development, assessing the properties and use of drugs in accordance with the principles of rational and individual therapy and evidence-based medicine. He/she is able to critically evaluate the latest knowledge in the biomedical field and respond to new technologies and trends. He/she is able to independently present the results of scientific work at international conferences and professional journals. He/she is able to communicate with biomedical specialists.
Graduates can find work in the laboratories of the pharmaceutical industry (e.g. preclinical/clinical research and development), hospitals (e.g. laboratories of molecular genetics), veterinary and nuclear medicine, academia/universities and research institutes.
By defending the dissertation thesis, the graduate demonstrates that he/she is capable of independent scientific work. Graduates will receive Ph.D. and meet the prerequisites for further career growth in the fields dealing with drugs and their therapeutic and toxic effects.
Related accreditations
| Faculty | Name of the study program | Language of instruction | Study form |
|---|---|---|---|
| Lékařská fakulta v Hradci Králové | Farmakologie a toxikologie | čeština | prezenční |
| Farmaceutická fakulta v Hradci Králové | Farmakologie a toxikologie | čeština | prezenční |
| Lékařská fakulta v Hradci Králové | Pharmacology and Toxicology | angličtina | kombinovaná |
| Lékařská fakulta v Hradci Králové | Pharmacology and Toxicology | angličtina | prezenční |
| Farmaceutická fakulta v Hradci Králové | Pharmacology and Toxicology | angličtina | prezenční |
| Farmaceutická fakulta v Hradci Králové | Pharmacology and Toxicology | angličtina | kombinovaná |
Teaching provided by
Faculty:
- Faculty of Medicine in Hradec Králové (LFHK)
- Faculty of Pharmacy in Hradec Králové (FaF) https://www.faf.cuni.cz
Cooperating institutions:
No
More details
Foreign university joint diploma type:
No
External department:
No
Classification
Area of education:
- Pharmacy
- General Medicine and Dentistry
SP structure
Specialisation:
No
Double-curriculum study:
No
Data for persons with disabilities
Contact person for persons with disability:
PhDr. Zděnka Kudláčková, Ph.D.
Web page for persons with disability:
Further information about the study of persons with disability:
Personal provision
Garant SP:
- prof. PharmDr. František Štaud, Ph.D.
More details
Subject Area Board Members:
- Chairman, Štaud František, prof. PharmDr., Ph.D. (from 25.4.2024)
- Members, Chládek Jaroslav, doc. Ing., Ph.D. (from 2.10.2025)
- Members, Čečková Martina, doc. PharmDr., Ph.D. (from 2.10.2025)
- Members, Červený Lukáš, doc. PharmDr., Ph.D. (from 2.10.2025)
- Members, Fusek Josef, prof. MUDr., DrSc., dr. h. c. (from 2.10.2025)
- Members, Jun Daniel, doc. PharmDr., Ph.D. (from 2.10.2025)
- Members, Kollár Peter, doc. PharmDr., Ph.D. (from 2.10.2025)
- Members, Macek Karel, MUDr., CSc. (from 2.10.2025)
- Members, Mičuda Stanislav, prof. MUDr., Ph.D. (from 2.10.2025)
- Members, Mladěnka Přemysl, prof. PharmDr., Ph.D. (from 2.10.2025)
- Members, Nachtigal Petr, prof. PharmDr., Ph.D. (from 2.10.2025)
- Members, Pávek Petr, prof. PharmDr., Ph.D. (from 2.10.2025)
- Members, Soukup Ondřej, prof. PharmDr., Ph.D. (from 2.10.2025)
- Members, Šimůnek Tomáš, prof. PharmDr., Ph.D. (from 2.10.2025)
- Members, Štěrba Martin, doc. PharmDr., Ph.D. (from 2.10.2025)
- Members, Trejtnar František, prof. PharmDr., CSc. (from 2.10.2025)
Instruction
Admission procedure requirements:
Study programme (branch) is open for applicants for the academic year
2026/2027:
- Faculty of Pharmacy in Hradec Králové - Admission procedure requirements
Admission procedure requirements in the acaademic year
2025/2026:
- Faculty of Pharmacy in Hradec Králové - Admission procedure requirements
- Faculty of Pharmacy in Hradec Králové - Admission procedure requirements - second run
Can be studied in combination
No combinations have been found